Skip to main content

Table 3 Cost-effectiveness analysis after 6-year follow-up time post-randomization

From: Cost-effectiveness analysis of oral nutritional supplements with nutritional counselling in head and neck cancer patients undergoing radiotherapy

Years

Mean OS [T (yr)]

Mean OS [C (yr)]

Difference (yr)

P-value

ICER (€/LYG)

1

0.863

0.885

− 0.022

0.57

407.27

2

1.504

1.581

− 0.077

0.47

112.43

3

2.077

2.134

− 0.058

0.74

144.21

4

2.627

2.603

0.025

0.91

− 323.26

5

3.153

3.025

0.129

0.68

− 60.53

6

3.636

3.400

0.236

0.54

− 31.97

  1. Discount rate = 3.5%; Incremental costs = -€8.96; ICER = Incremental cost/LYG; Mean OS = mean survival at a given point calculated as the area under Kaplan–Meier curves
  2. T treatment, C control, Yr year